Diseases caused by altered specificity of a protein kinase for its allosteric activators

被引:0
|
作者
Cohen, Philip [1 ]
Snelling, Tom [1 ]
机构
[1] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland
基金
英国惠康基金; 英国医学研究理事会;
关键词
NF-KAPPA-B; DEPENDENT KINASE; DISCOVERY; HEPTOSES; BINDING;
D O I
10.1016/j.tibs.2024.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases regulate many intracellular processes, and their dysregulation causes cancers and other diseases. This review focuses on the atypical alpha-kinase 1 (ALPK1), which is activated in mammalian cells by nucleoside diphosphate heptoses (ADP-heptose, UDP-heptose, and CDP-heptose) produced by microbial pathogens but not by mammalian cells. Mutations in human ALPK1 cause ROSAH syndrome and spiradenoma, which result from an alteration in its specificity for nucleoside diphosphate heptoses, causing aberrant activation by mammalian nucleoside diphosphate sugars without microbial infection. These may be the first diseases caused by altered specificity of an enzyme for its allosteric activators and has suggested ways in which selective drugs could be developed to treat them without compromising the innate immune system.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 50 条
  • [41] Systematic Analysis of Covalent and Allosteric Protein Kinase Inhibitors
    Xerxa, Elena
    Laufkoetter, Oliver
    Bajorath, Jurgen
    MOLECULES, 2023, 28 (15):
  • [42] Dynamic infrastructure of a protein kinase core and allosteric signaling
    Kornev, Alexandr P.
    Taylor, Susan S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [43] Single Molecule Analysis of Allosteric Interactions in Protein Kinase A
    Hao, Yuxin
    England, Jeneffer
    Taylor, Susan S.
    Maillard, Rodrigo A.
    FASEB JOURNAL, 2016, 30
  • [44] Allosteric modulators of a protein kinase via disulfide trapping
    Sadowsky, Jack D.
    Wells, James A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [45] Protein kinase C - A family of protein kinases, allosteric effectors or both?
    Cameron, Angus J. M.
    Parker, Peter J.
    ADVANCES IN ENZYME REGULATION, VOL 50, 2010, 50 : 169 - +
  • [46] ALKYL ANALOGS OF DIACYLGLYCEROL AS ACTIVATORS OF PROTEIN-KINASE-C
    HEYMANS, F
    DASILVA, C
    MARREC, N
    GODFROID, JJ
    CASTAGNA, M
    FEBS LETTERS, 1987, 218 (01) : 35 - 40
  • [47] EFFECTS OF PROTEIN-KINASE-C ACTIVATORS ON HUMAN BASOPHILS
    AMON, U
    VONSTEBUT, E
    WOLFF, HH
    AGENTS AND ACTIONS, 1993, 38 : C239 - C241
  • [48] Protein kinase C substrate activators: Potential as novel antidepressants
    Sun, MK
    Alkon, DL
    DRUG DEVELOPMENT RESEARCH, 2005, 65 (03) : 156 - 169
  • [49] PROTEIN-KINASE ACTIVATORS ALTER GLIAL CHOLESTEROL ESTERIFICATION
    JENG, I
    DILLS, C
    KLEMM, N
    WU, C
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1670 - 1670
  • [50] STRUCTURAL ANALOGIES BETWEEN PROTEIN KINASE-C ACTIVATORS
    BRASSEUR, R
    CABIAUX, V
    HUART, P
    CASTAGNA, M
    BAZTAR, S
    RUYSSCHAERT, JM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 127 (03) : 969 - 976